nodes	percent_of_prediction	percent_of_DWPC	metapath
Histamine Phosphate—CYP2D6—breast cancer	0.127	0.538	CbGaD
Histamine Phosphate—SLC22A3—Melphalan—breast cancer	0.117	0.266	CbGbCtD
Histamine Phosphate—CYP3A4—breast cancer	0.109	0.462	CbGaD
Histamine Phosphate—SLC22A3—Irinotecan—breast cancer	0.0395	0.09	CbGbCtD
Histamine Phosphate—CYP2C9—Anastrozole—breast cancer	0.025	0.057	CbGbCtD
Histamine Phosphate—SLC22A2—Vinblastine—breast cancer	0.0208	0.0474	CbGbCtD
Histamine Phosphate—CYP3A4—Exemestane—breast cancer	0.0192	0.0437	CbGbCtD
Histamine Phosphate—CYP2C9—Idarubicin—breast cancer	0.019	0.0432	CbGbCtD
Histamine Phosphate—CYP2D6—Idarubicin—breast cancer	0.0173	0.0395	CbGbCtD
Histamine Phosphate—CYP3A4—Letrozole—breast cancer	0.0163	0.0372	CbGbCtD
Histamine Phosphate—CYP3A4—Anastrozole—breast cancer	0.0145	0.0331	CbGbCtD
Histamine Phosphate—CYP3A4—Toremifene—breast cancer	0.0133	0.0303	CbGbCtD
Histamine Phosphate—CYP3A4—Fulvestrant—breast cancer	0.0124	0.0282	CbGbCtD
Histamine Phosphate—CYP3A4—Thiotepa—breast cancer	0.011	0.0251	CbGbCtD
Histamine Phosphate—CYP2C9—Capecitabine—breast cancer	0.0104	0.0237	CbGbCtD
Histamine Phosphate—CYP3A4—Ixabepilone—breast cancer	0.0101	0.023	CbGbCtD
Histamine Phosphate—CYP3A4—Lapatinib—breast cancer	0.0097	0.0221	CbGbCtD
Histamine Phosphate—CYP2D6—Vinorelbine—breast cancer	0.00846	0.0193	CbGbCtD
Histamine Phosphate—CYP2C9—Tamoxifen—breast cancer	0.00836	0.019	CbGbCtD
Histamine Phosphate—CYP2D6—Tamoxifen—breast cancer	0.00764	0.0174	CbGbCtD
Histamine Phosphate—CYP3A4—Raloxifene—breast cancer	0.00735	0.0168	CbGbCtD
Histamine Phosphate—CYP2C9—Paclitaxel—breast cancer	0.0065	0.0148	CbGbCtD
Histamine Phosphate—CYP2C9—Fluorouracil—breast cancer	0.00616	0.014	CbGbCtD
Histamine Phosphate—CYP3A4—Vinorelbine—breast cancer	0.00538	0.0123	CbGbCtD
Histamine Phosphate—CYP2D6—Vinblastine—breast cancer	0.00522	0.0119	CbGbCtD
Histamine Phosphate—CYP3A4—Tamoxifen—breast cancer	0.00486	0.0111	CbGbCtD
Histamine Phosphate—CYP3A4—Mitoxantrone—breast cancer	0.00474	0.0108	CbGbCtD
Histamine Phosphate—CYP3A4—Paclitaxel—breast cancer	0.00378	0.00862	CbGbCtD
Histamine Phosphate—CYP3A4—Irinotecan—breast cancer	0.00373	0.0085	CbGbCtD
Histamine Phosphate—CYP3A4—Vinblastine—breast cancer	0.00332	0.00756	CbGbCtD
Histamine Phosphate—CYP2D6—Doxorubicin—breast cancer	0.00321	0.0073	CbGbCtD
Histamine Phosphate—CYP3A4—Docetaxel—breast cancer	0.00273	0.00623	CbGbCtD
Histamine Phosphate—HNMT—mammary gland—breast cancer	0.00234	0.0728	CbGeAlD
Histamine Phosphate—CYP3A4—Doxorubicin—breast cancer	0.00204	0.00464	CbGbCtD
Histamine Phosphate—HRH4—bone marrow—breast cancer	0.00168	0.0524	CbGeAlD
Histamine Phosphate—HNMT—epithelium—breast cancer	0.0013	0.0406	CbGeAlD
Histamine Phosphate—HNMT—adipose tissue—breast cancer	0.00105	0.0328	CbGeAlD
Histamine Phosphate—HNMT—female reproductive system—breast cancer	0.000968	0.0301	CbGeAlD
Histamine Phosphate—HRH2—skin of body—breast cancer	0.000959	0.0298	CbGeAlD
Histamine Phosphate—HNMT—adrenal gland—breast cancer	0.000945	0.0294	CbGeAlD
Histamine Phosphate—SLC22A3—nipple—breast cancer	0.000922	0.0287	CbGeAlD
Histamine Phosphate—HNMT—female gonad—breast cancer	0.000881	0.0274	CbGeAlD
Histamine Phosphate—CA4—nipple—breast cancer	0.000822	0.0256	CbGeAlD
Histamine Phosphate—HNMT—endocrine gland—breast cancer	0.00082	0.0255	CbGeAlD
Histamine Phosphate—SLC22A5—mammary gland—breast cancer	0.00081	0.0252	CbGeAlD
Histamine Phosphate—SLC22A3—embryo—breast cancer	0.000761	0.0237	CbGeAlD
Histamine Phosphate—HRH2—adrenal gland—breast cancer	0.000731	0.0227	CbGeAlD
Histamine Phosphate—CYP2C9—mammary gland—breast cancer	0.000697	0.0217	CbGeAlD
Histamine Phosphate—SLC22A5—nipple—breast cancer	0.00067	0.0209	CbGeAlD
Histamine Phosphate—HRH2—endocrine gland—breast cancer	0.000634	0.0197	CbGeAlD
Histamine Phosphate—HRH1—nipple—breast cancer	0.000568	0.0177	CbGeAlD
Histamine Phosphate—HNMT—lymph node—breast cancer	0.000567	0.0176	CbGeAlD
Histamine Phosphate—SLC22A3—endometrium—breast cancer	0.000557	0.0173	CbGeAlD
Histamine Phosphate—SLC22A1—adipose tissue—breast cancer	0.000525	0.0163	CbGeAlD
Histamine Phosphate—SLC22A3—adipose tissue—breast cancer	0.000502	0.0156	CbGeAlD
Histamine Phosphate—SLC22A3—female reproductive system—breast cancer	0.000461	0.0143	CbGeAlD
Histamine Phosphate—SLC22A3—adrenal gland—breast cancer	0.00045	0.014	CbGeAlD
Histamine Phosphate—CA4—pituitary gland—breast cancer	0.000449	0.014	CbGeAlD
Histamine Phosphate—CA4—adipose tissue—breast cancer	0.000447	0.0139	CbGeAlD
Histamine Phosphate—HRH2—lymph node—breast cancer	0.000438	0.0136	CbGeAlD
Histamine Phosphate—SLC22A5—skin of body—breast cancer	0.000429	0.0134	CbGeAlD
Histamine Phosphate—SLC22A3—female gonad—breast cancer	0.00042	0.0131	CbGeAlD
Histamine Phosphate—CA4—female reproductive system—breast cancer	0.000411	0.0128	CbGeAlD
Histamine Phosphate—SLC22A1—endocrine gland—breast cancer	0.000408	0.0127	CbGeAlD
Histamine Phosphate—SLC22A5—endometrium—breast cancer	0.000405	0.0126	CbGeAlD
Histamine Phosphate—CA4—adrenal gland—breast cancer	0.000401	0.0125	CbGeAlD
Histamine Phosphate—SLC22A3—endocrine gland—breast cancer	0.00039	0.0121	CbGeAlD
Histamine Phosphate—CA4—bone marrow—breast cancer	0.000388	0.0121	CbGeAlD
Histamine Phosphate—HRH1—epithelium—breast cancer	0.000383	0.0119	CbGeAlD
Histamine Phosphate—CA4—female gonad—breast cancer	0.000374	0.0116	CbGeAlD
Histamine Phosphate—SLC22A5—pituitary gland—breast cancer	0.000366	0.0114	CbGeAlD
Histamine Phosphate—SLC22A5—adipose tissue—breast cancer	0.000365	0.0113	CbGeAlD
Histamine Phosphate—CA4—endocrine gland—breast cancer	0.000348	0.0108	CbGeAlD
Histamine Phosphate—HRH1—endometrium—breast cancer	0.000343	0.0107	CbGeAlD
Histamine Phosphate—SLC22A5—female reproductive system—breast cancer	0.000335	0.0104	CbGeAlD
Histamine Phosphate—SLC22A5—adrenal gland—breast cancer	0.000327	0.0102	CbGeAlD
Histamine Phosphate—HRH1—adipose tissue—breast cancer	0.000309	0.00962	CbGeAlD
Histamine Phosphate—SLC22A5—female gonad—breast cancer	0.000305	0.00949	CbGeAlD
Histamine Phosphate—CYP2C9—female reproductive system—breast cancer	0.000288	0.00897	CbGeAlD
Histamine Phosphate—HRH1—female reproductive system—breast cancer	0.000284	0.00885	CbGeAlD
Histamine Phosphate—HRH1—adrenal gland—breast cancer	0.000277	0.00863	CbGeAlD
Histamine Phosphate—SLC22A3—lymph node—breast cancer	0.00027	0.00839	CbGeAlD
Histamine Phosphate—HRH1—female gonad—breast cancer	0.000259	0.00805	CbGeAlD
Histamine Phosphate—CYP2C9—endocrine gland—breast cancer	0.000244	0.00759	CbGeAlD
Histamine Phosphate—HRH1—endocrine gland—breast cancer	0.000241	0.00749	CbGeAlD
Histamine Phosphate—CA4—lymph node—breast cancer	0.00024	0.00748	CbGeAlD
Histamine Phosphate—CYP3A4—female reproductive system—breast cancer	0.00022	0.00684	CbGeAlD
Histamine Phosphate—CYP2D6—female reproductive system—breast cancer	0.000216	0.00673	CbGeAlD
Histamine Phosphate—CYP2D6—female gonad—breast cancer	0.000197	0.00612	CbGeAlD
Histamine Phosphate—SLC22A5—lymph node—breast cancer	0.000196	0.0061	CbGeAlD
Histamine Phosphate—CYP3A4—endocrine gland—breast cancer	0.000186	0.00579	CbGeAlD
Histamine Phosphate—CYP2D6—endocrine gland—breast cancer	0.000183	0.0057	CbGeAlD
Histamine Phosphate—HRH1—lymph node—breast cancer	0.000166	0.00517	CbGeAlD
Histamine Phosphate—Dyspnoea—Docetaxel—breast cancer	4.3e-05	0.000219	CcSEcCtD
Histamine Phosphate—Mental disorder—Methotrexate—breast cancer	4.28e-05	0.000218	CcSEcCtD
Histamine Phosphate—Rash—Gemcitabine—breast cancer	4.28e-05	0.000218	CcSEcCtD
Histamine Phosphate—Dermatitis—Gemcitabine—breast cancer	4.28e-05	0.000218	CcSEcCtD
Histamine Phosphate—Erythema—Methotrexate—breast cancer	4.25e-05	0.000217	CcSEcCtD
Histamine Phosphate—Malnutrition—Methotrexate—breast cancer	4.25e-05	0.000217	CcSEcCtD
Histamine Phosphate—Headache—Gemcitabine—breast cancer	4.25e-05	0.000217	CcSEcCtD
Histamine Phosphate—Musculoskeletal discomfort—Capecitabine—breast cancer	4.25e-05	0.000217	CcSEcCtD
Histamine Phosphate—Flushing—Epirubicin—breast cancer	4.25e-05	0.000216	CcSEcCtD
Histamine Phosphate—Cardiac disorder—Epirubicin—breast cancer	4.25e-05	0.000216	CcSEcCtD
Histamine Phosphate—Vomiting—Fluorouracil—breast cancer	4.24e-05	0.000216	CcSEcCtD
Histamine Phosphate—Dyspepsia—Docetaxel—breast cancer	4.24e-05	0.000216	CcSEcCtD
Histamine Phosphate—Insomnia—Capecitabine—breast cancer	4.22e-05	0.000215	CcSEcCtD
Histamine Phosphate—Hypoaesthesia—Doxorubicin—breast cancer	4.21e-05	0.000215	CcSEcCtD
Histamine Phosphate—Rash—Fluorouracil—breast cancer	4.21e-05	0.000215	CcSEcCtD
Histamine Phosphate—Dermatitis—Fluorouracil—breast cancer	4.2e-05	0.000214	CcSEcCtD
Histamine Phosphate—Paraesthesia—Capecitabine—breast cancer	4.19e-05	0.000214	CcSEcCtD
Histamine Phosphate—Decreased appetite—Docetaxel—breast cancer	4.19e-05	0.000214	CcSEcCtD
Histamine Phosphate—Hypersensitivity—Paclitaxel—breast cancer	4.19e-05	0.000213	CcSEcCtD
Histamine Phosphate—Headache—Fluorouracil—breast cancer	4.18e-05	0.000213	CcSEcCtD
Histamine Phosphate—Oedema peripheral—Doxorubicin—breast cancer	4.17e-05	0.000213	CcSEcCtD
Histamine Phosphate—Dysgeusia—Methotrexate—breast cancer	4.17e-05	0.000212	CcSEcCtD
Histamine Phosphate—Gastrointestinal disorder—Docetaxel—breast cancer	4.16e-05	0.000212	CcSEcCtD
Histamine Phosphate—Connective tissue disorder—Doxorubicin—breast cancer	4.16e-05	0.000212	CcSEcCtD
Histamine Phosphate—Dyspnoea—Capecitabine—breast cancer	4.16e-05	0.000212	CcSEcCtD
Histamine Phosphate—Fatigue—Docetaxel—breast cancer	4.15e-05	0.000212	CcSEcCtD
Histamine Phosphate—Angiopathy—Epirubicin—breast cancer	4.15e-05	0.000212	CcSEcCtD
Histamine Phosphate—Nausea—Mitoxantrone—breast cancer	4.14e-05	0.000211	CcSEcCtD
Histamine Phosphate—Nausea—Irinotecan—breast cancer	4.14e-05	0.000211	CcSEcCtD
Histamine Phosphate—Mediastinal disorder—Epirubicin—breast cancer	4.12e-05	0.00021	CcSEcCtD
Histamine Phosphate—Pain—Docetaxel—breast cancer	4.12e-05	0.00021	CcSEcCtD
Histamine Phosphate—Constipation—Docetaxel—breast cancer	4.12e-05	0.00021	CcSEcCtD
Histamine Phosphate—Back pain—Methotrexate—breast cancer	4.12e-05	0.00021	CcSEcCtD
Histamine Phosphate—Dyspepsia—Capecitabine—breast cancer	4.11e-05	0.000209	CcSEcCtD
Histamine Phosphate—Chills—Epirubicin—breast cancer	4.1e-05	0.000209	CcSEcCtD
Histamine Phosphate—Arrhythmia—Epirubicin—breast cancer	4.09e-05	0.000208	CcSEcCtD
Histamine Phosphate—Asthenia—Paclitaxel—breast cancer	4.08e-05	0.000208	CcSEcCtD
Histamine Phosphate—Decreased appetite—Capecitabine—breast cancer	4.05e-05	0.000207	CcSEcCtD
Histamine Phosphate—Nausea—Gemcitabine—breast cancer	4.03e-05	0.000206	CcSEcCtD
Histamine Phosphate—Gastrointestinal disorder—Capecitabine—breast cancer	4.03e-05	0.000205	CcSEcCtD
Histamine Phosphate—Fatigue—Capecitabine—breast cancer	4.02e-05	0.000205	CcSEcCtD
Histamine Phosphate—Pruritus—Paclitaxel—breast cancer	4.02e-05	0.000205	CcSEcCtD
Histamine Phosphate—Mental disorder—Epirubicin—breast cancer	4.01e-05	0.000204	CcSEcCtD
Histamine Phosphate—Pain—Capecitabine—breast cancer	3.99e-05	0.000203	CcSEcCtD
Histamine Phosphate—Constipation—Capecitabine—breast cancer	3.99e-05	0.000203	CcSEcCtD
Histamine Phosphate—Erythema—Epirubicin—breast cancer	3.98e-05	0.000203	CcSEcCtD
Histamine Phosphate—Malnutrition—Epirubicin—breast cancer	3.98e-05	0.000203	CcSEcCtD
Histamine Phosphate—Feeling abnormal—Docetaxel—breast cancer	3.97e-05	0.000202	CcSEcCtD
Histamine Phosphate—Nausea—Fluorouracil—breast cancer	3.96e-05	0.000202	CcSEcCtD
Histamine Phosphate—Ill-defined disorder—Methotrexate—breast cancer	3.95e-05	0.000201	CcSEcCtD
Histamine Phosphate—Gastrointestinal pain—Docetaxel—breast cancer	3.94e-05	0.000201	CcSEcCtD
Histamine Phosphate—Anaemia—Methotrexate—breast cancer	3.93e-05	0.0002	CcSEcCtD
Histamine Phosphate—Flushing—Doxorubicin—breast cancer	3.93e-05	0.0002	CcSEcCtD
Histamine Phosphate—Cardiac disorder—Doxorubicin—breast cancer	3.93e-05	0.0002	CcSEcCtD
Histamine Phosphate—Flatulence—Epirubicin—breast cancer	3.92e-05	0.0002	CcSEcCtD
Histamine Phosphate—Dysgeusia—Epirubicin—breast cancer	3.9e-05	0.000199	CcSEcCtD
Histamine Phosphate—Diarrhoea—Paclitaxel—breast cancer	3.89e-05	0.000198	CcSEcCtD
Histamine Phosphate—Risedronate—PTGS2—breast cancer	3.87e-05	1	CrCbGaD
Histamine Phosphate—Back pain—Epirubicin—breast cancer	3.85e-05	0.000196	CcSEcCtD
Histamine Phosphate—Feeling abnormal—Capecitabine—breast cancer	3.84e-05	0.000196	CcSEcCtD
Histamine Phosphate—Angiopathy—Doxorubicin—breast cancer	3.84e-05	0.000196	CcSEcCtD
Histamine Phosphate—Malaise—Methotrexate—breast cancer	3.84e-05	0.000196	CcSEcCtD
Histamine Phosphate—Muscle spasms—Epirubicin—breast cancer	3.83e-05	0.000195	CcSEcCtD
Histamine Phosphate—Vertigo—Methotrexate—breast cancer	3.82e-05	0.000195	CcSEcCtD
Histamine Phosphate—Gastrointestinal pain—Capecitabine—breast cancer	3.81e-05	0.000194	CcSEcCtD
Histamine Phosphate—Mediastinal disorder—Doxorubicin—breast cancer	3.81e-05	0.000194	CcSEcCtD
Histamine Phosphate—Body temperature increased—Docetaxel—breast cancer	3.81e-05	0.000194	CcSEcCtD
Histamine Phosphate—Abdominal pain—Docetaxel—breast cancer	3.81e-05	0.000194	CcSEcCtD
Histamine Phosphate—Leukopenia—Methotrexate—breast cancer	3.81e-05	0.000194	CcSEcCtD
Histamine Phosphate—Chills—Doxorubicin—breast cancer	3.8e-05	0.000194	CcSEcCtD
Histamine Phosphate—Arrhythmia—Doxorubicin—breast cancer	3.78e-05	0.000193	CcSEcCtD
Histamine Phosphate—Dizziness—Paclitaxel—breast cancer	3.76e-05	0.000192	CcSEcCtD
Histamine Phosphate—Cough—Methotrexate—breast cancer	3.71e-05	0.000189	CcSEcCtD
Histamine Phosphate—Mental disorder—Doxorubicin—breast cancer	3.71e-05	0.000189	CcSEcCtD
Histamine Phosphate—Urticaria—Capecitabine—breast cancer	3.71e-05	0.000189	CcSEcCtD
Histamine Phosphate—Ill-defined disorder—Epirubicin—breast cancer	3.69e-05	0.000188	CcSEcCtD
Histamine Phosphate—Abdominal pain—Capecitabine—breast cancer	3.69e-05	0.000188	CcSEcCtD
Histamine Phosphate—Body temperature increased—Capecitabine—breast cancer	3.69e-05	0.000188	CcSEcCtD
Histamine Phosphate—Convulsion—Methotrexate—breast cancer	3.69e-05	0.000188	CcSEcCtD
Histamine Phosphate—Erythema—Doxorubicin—breast cancer	3.68e-05	0.000188	CcSEcCtD
Histamine Phosphate—Malnutrition—Doxorubicin—breast cancer	3.68e-05	0.000188	CcSEcCtD
Histamine Phosphate—Anaemia—Epirubicin—breast cancer	3.68e-05	0.000188	CcSEcCtD
Histamine Phosphate—Flatulence—Doxorubicin—breast cancer	3.63e-05	0.000185	CcSEcCtD
Histamine Phosphate—Chest pain—Methotrexate—breast cancer	3.62e-05	0.000185	CcSEcCtD
Histamine Phosphate—Arthralgia—Methotrexate—breast cancer	3.62e-05	0.000185	CcSEcCtD
Histamine Phosphate—Myalgia—Methotrexate—breast cancer	3.62e-05	0.000185	CcSEcCtD
Histamine Phosphate—Vomiting—Paclitaxel—breast cancer	3.61e-05	0.000184	CcSEcCtD
Histamine Phosphate—Dysgeusia—Doxorubicin—breast cancer	3.61e-05	0.000184	CcSEcCtD
Histamine Phosphate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	3.6e-05	0.000183	CcSEcCtD
Histamine Phosphate—Malaise—Epirubicin—breast cancer	3.59e-05	0.000183	CcSEcCtD
Histamine Phosphate—Rash—Paclitaxel—breast cancer	3.58e-05	0.000183	CcSEcCtD
Histamine Phosphate—Dermatitis—Paclitaxel—breast cancer	3.58e-05	0.000183	CcSEcCtD
Histamine Phosphate—Discomfort—Methotrexate—breast cancer	3.58e-05	0.000182	CcSEcCtD
Histamine Phosphate—Vertigo—Epirubicin—breast cancer	3.58e-05	0.000182	CcSEcCtD
Histamine Phosphate—Leukopenia—Epirubicin—breast cancer	3.56e-05	0.000182	CcSEcCtD
Histamine Phosphate—Back pain—Doxorubicin—breast cancer	3.56e-05	0.000182	CcSEcCtD
Histamine Phosphate—Headache—Paclitaxel—breast cancer	3.56e-05	0.000182	CcSEcCtD
Histamine Phosphate—Hypersensitivity—Docetaxel—breast cancer	3.55e-05	0.000181	CcSEcCtD
Histamine Phosphate—Muscle spasms—Doxorubicin—breast cancer	3.54e-05	0.000181	CcSEcCtD
Histamine Phosphate—Palpitations—Epirubicin—breast cancer	3.52e-05	0.000179	CcSEcCtD
Histamine Phosphate—Confusional state—Methotrexate—breast cancer	3.5e-05	0.000178	CcSEcCtD
Histamine Phosphate—Cough—Epirubicin—breast cancer	3.47e-05	0.000177	CcSEcCtD
Histamine Phosphate—Anaphylactic shock—Methotrexate—breast cancer	3.47e-05	0.000177	CcSEcCtD
Histamine Phosphate—Asthenia—Docetaxel—breast cancer	3.46e-05	0.000176	CcSEcCtD
Histamine Phosphate—Convulsion—Epirubicin—breast cancer	3.45e-05	0.000176	CcSEcCtD
Histamine Phosphate—Infection—Methotrexate—breast cancer	3.45e-05	0.000176	CcSEcCtD
Histamine Phosphate—Hypertension—Epirubicin—breast cancer	3.44e-05	0.000175	CcSEcCtD
Histamine Phosphate—Hypersensitivity—Capecitabine—breast cancer	3.44e-05	0.000175	CcSEcCtD
Histamine Phosphate—Ill-defined disorder—Doxorubicin—breast cancer	3.42e-05	0.000174	CcSEcCtD
Histamine Phosphate—Pruritus—Docetaxel—breast cancer	3.41e-05	0.000174	CcSEcCtD
Histamine Phosphate—Nervous system disorder—Methotrexate—breast cancer	3.41e-05	0.000174	CcSEcCtD
Histamine Phosphate—Anaemia—Doxorubicin—breast cancer	3.41e-05	0.000174	CcSEcCtD
Histamine Phosphate—Thrombocytopenia—Methotrexate—breast cancer	3.4e-05	0.000173	CcSEcCtD
Histamine Phosphate—Chest pain—Epirubicin—breast cancer	3.39e-05	0.000173	CcSEcCtD
Histamine Phosphate—Myalgia—Epirubicin—breast cancer	3.39e-05	0.000173	CcSEcCtD
Histamine Phosphate—Arthralgia—Epirubicin—breast cancer	3.39e-05	0.000173	CcSEcCtD
Histamine Phosphate—Anxiety—Epirubicin—breast cancer	3.38e-05	0.000172	CcSEcCtD
Histamine Phosphate—Nausea—Paclitaxel—breast cancer	3.38e-05	0.000172	CcSEcCtD
Histamine Phosphate—Skin disorder—Methotrexate—breast cancer	3.37e-05	0.000172	CcSEcCtD
Histamine Phosphate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	3.37e-05	0.000172	CcSEcCtD
Histamine Phosphate—Hyperhidrosis—Methotrexate—breast cancer	3.36e-05	0.000171	CcSEcCtD
Histamine Phosphate—Discomfort—Epirubicin—breast cancer	3.35e-05	0.000171	CcSEcCtD
Histamine Phosphate—Asthenia—Capecitabine—breast cancer	3.35e-05	0.000171	CcSEcCtD
Histamine Phosphate—Malaise—Doxorubicin—breast cancer	3.32e-05	0.000169	CcSEcCtD
Histamine Phosphate—Dry mouth—Epirubicin—breast cancer	3.32e-05	0.000169	CcSEcCtD
Histamine Phosphate—Vertigo—Doxorubicin—breast cancer	3.31e-05	0.000169	CcSEcCtD
Histamine Phosphate—Anorexia—Methotrexate—breast cancer	3.31e-05	0.000169	CcSEcCtD
Histamine Phosphate—Pruritus—Capecitabine—breast cancer	3.3e-05	0.000168	CcSEcCtD
Histamine Phosphate—Leukopenia—Doxorubicin—breast cancer	3.3e-05	0.000168	CcSEcCtD
Histamine Phosphate—Diarrhoea—Docetaxel—breast cancer	3.3e-05	0.000168	CcSEcCtD
Histamine Phosphate—Confusional state—Epirubicin—breast cancer	3.28e-05	0.000167	CcSEcCtD
Histamine Phosphate—Palpitations—Doxorubicin—breast cancer	3.26e-05	0.000166	CcSEcCtD
Histamine Phosphate—Anaphylactic shock—Epirubicin—breast cancer	3.25e-05	0.000166	CcSEcCtD
Histamine Phosphate—Hypotension—Methotrexate—breast cancer	3.24e-05	0.000165	CcSEcCtD
Histamine Phosphate—Infection—Epirubicin—breast cancer	3.23e-05	0.000165	CcSEcCtD
Histamine Phosphate—Cough—Doxorubicin—breast cancer	3.21e-05	0.000164	CcSEcCtD
Histamine Phosphate—Shock—Epirubicin—breast cancer	3.2e-05	0.000163	CcSEcCtD
Histamine Phosphate—Convulsion—Doxorubicin—breast cancer	3.19e-05	0.000163	CcSEcCtD
Histamine Phosphate—Diarrhoea—Capecitabine—breast cancer	3.19e-05	0.000163	CcSEcCtD
Histamine Phosphate—Nervous system disorder—Epirubicin—breast cancer	3.19e-05	0.000162	CcSEcCtD
Histamine Phosphate—Dizziness—Docetaxel—breast cancer	3.19e-05	0.000162	CcSEcCtD
Histamine Phosphate—Thrombocytopenia—Epirubicin—breast cancer	3.18e-05	0.000162	CcSEcCtD
Histamine Phosphate—Hypertension—Doxorubicin—breast cancer	3.18e-05	0.000162	CcSEcCtD
Histamine Phosphate—Tachycardia—Epirubicin—breast cancer	3.17e-05	0.000162	CcSEcCtD
Histamine Phosphate—Musculoskeletal discomfort—Methotrexate—breast cancer	3.16e-05	0.000161	CcSEcCtD
Histamine Phosphate—Skin disorder—Epirubicin—breast cancer	3.16e-05	0.000161	CcSEcCtD
Histamine Phosphate—Hyperhidrosis—Epirubicin—breast cancer	3.14e-05	0.00016	CcSEcCtD
Histamine Phosphate—Insomnia—Methotrexate—breast cancer	3.14e-05	0.00016	CcSEcCtD
Histamine Phosphate—Chest pain—Doxorubicin—breast cancer	3.14e-05	0.00016	CcSEcCtD
Histamine Phosphate—Myalgia—Doxorubicin—breast cancer	3.14e-05	0.00016	CcSEcCtD
Histamine Phosphate—Arthralgia—Doxorubicin—breast cancer	3.14e-05	0.00016	CcSEcCtD
Histamine Phosphate—Anxiety—Doxorubicin—breast cancer	3.13e-05	0.000159	CcSEcCtD
Histamine Phosphate—Paraesthesia—Methotrexate—breast cancer	3.12e-05	0.000159	CcSEcCtD
Histamine Phosphate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	3.12e-05	0.000159	CcSEcCtD
Histamine Phosphate—Discomfort—Doxorubicin—breast cancer	3.1e-05	0.000158	CcSEcCtD
Histamine Phosphate—Anorexia—Epirubicin—breast cancer	3.1e-05	0.000158	CcSEcCtD
Histamine Phosphate—Dyspnoea—Methotrexate—breast cancer	3.1e-05	0.000158	CcSEcCtD
Histamine Phosphate—Dizziness—Capecitabine—breast cancer	3.08e-05	0.000157	CcSEcCtD
Histamine Phosphate—Dry mouth—Doxorubicin—breast cancer	3.07e-05	0.000156	CcSEcCtD
Histamine Phosphate—Vomiting—Docetaxel—breast cancer	3.06e-05	0.000156	CcSEcCtD
Histamine Phosphate—Dyspepsia—Methotrexate—breast cancer	3.06e-05	0.000156	CcSEcCtD
Histamine Phosphate—Rash—Docetaxel—breast cancer	3.04e-05	0.000155	CcSEcCtD
Histamine Phosphate—Hypotension—Epirubicin—breast cancer	3.04e-05	0.000155	CcSEcCtD
Histamine Phosphate—Dermatitis—Docetaxel—breast cancer	3.03e-05	0.000155	CcSEcCtD
Histamine Phosphate—Confusional state—Doxorubicin—breast cancer	3.03e-05	0.000155	CcSEcCtD
Histamine Phosphate—Decreased appetite—Methotrexate—breast cancer	3.02e-05	0.000154	CcSEcCtD
Histamine Phosphate—Headache—Docetaxel—breast cancer	3.02e-05	0.000154	CcSEcCtD
Histamine Phosphate—Anaphylactic shock—Doxorubicin—breast cancer	3.01e-05	0.000153	CcSEcCtD
Histamine Phosphate—Gastrointestinal disorder—Methotrexate—breast cancer	3e-05	0.000153	CcSEcCtD
Histamine Phosphate—Fatigue—Methotrexate—breast cancer	2.99e-05	0.000153	CcSEcCtD
Histamine Phosphate—Infection—Doxorubicin—breast cancer	2.99e-05	0.000152	CcSEcCtD
Histamine Phosphate—Pain—Methotrexate—breast cancer	2.97e-05	0.000151	CcSEcCtD
Histamine Phosphate—Vomiting—Capecitabine—breast cancer	2.97e-05	0.000151	CcSEcCtD
Histamine Phosphate—Musculoskeletal discomfort—Epirubicin—breast cancer	2.96e-05	0.000151	CcSEcCtD
Histamine Phosphate—Shock—Doxorubicin—breast cancer	2.96e-05	0.000151	CcSEcCtD
Histamine Phosphate—Nervous system disorder—Doxorubicin—breast cancer	2.95e-05	0.00015	CcSEcCtD
Histamine Phosphate—Thrombocytopenia—Doxorubicin—breast cancer	2.94e-05	0.00015	CcSEcCtD
Histamine Phosphate—Rash—Capecitabine—breast cancer	2.94e-05	0.00015	CcSEcCtD
Histamine Phosphate—Insomnia—Epirubicin—breast cancer	2.94e-05	0.00015	CcSEcCtD
Histamine Phosphate—Dermatitis—Capecitabine—breast cancer	2.94e-05	0.00015	CcSEcCtD
Histamine Phosphate—Tachycardia—Doxorubicin—breast cancer	2.93e-05	0.00015	CcSEcCtD
Histamine Phosphate—Headache—Capecitabine—breast cancer	2.92e-05	0.000149	CcSEcCtD
Histamine Phosphate—Skin disorder—Doxorubicin—breast cancer	2.92e-05	0.000149	CcSEcCtD
Histamine Phosphate—Paraesthesia—Epirubicin—breast cancer	2.92e-05	0.000149	CcSEcCtD
Histamine Phosphate—Hyperhidrosis—Doxorubicin—breast cancer	2.91e-05	0.000148	CcSEcCtD
Histamine Phosphate—Dyspnoea—Epirubicin—breast cancer	2.9e-05	0.000148	CcSEcCtD
Histamine Phosphate—Anorexia—Doxorubicin—breast cancer	2.87e-05	0.000146	CcSEcCtD
Histamine Phosphate—Nausea—Docetaxel—breast cancer	2.86e-05	0.000146	CcSEcCtD
Histamine Phosphate—Feeling abnormal—Methotrexate—breast cancer	2.86e-05	0.000146	CcSEcCtD
Histamine Phosphate—Dyspepsia—Epirubicin—breast cancer	2.86e-05	0.000146	CcSEcCtD
Histamine Phosphate—Gastrointestinal pain—Methotrexate—breast cancer	2.84e-05	0.000145	CcSEcCtD
Histamine Phosphate—Decreased appetite—Epirubicin—breast cancer	2.82e-05	0.000144	CcSEcCtD
Histamine Phosphate—Hypotension—Doxorubicin—breast cancer	2.81e-05	0.000143	CcSEcCtD
Histamine Phosphate—Gastrointestinal disorder—Epirubicin—breast cancer	2.81e-05	0.000143	CcSEcCtD
Histamine Phosphate—Fatigue—Epirubicin—breast cancer	2.8e-05	0.000143	CcSEcCtD
Histamine Phosphate—Pain—Epirubicin—breast cancer	2.78e-05	0.000142	CcSEcCtD
Histamine Phosphate—Constipation—Epirubicin—breast cancer	2.78e-05	0.000142	CcSEcCtD
Histamine Phosphate—Nausea—Capecitabine—breast cancer	2.77e-05	0.000141	CcSEcCtD
Histamine Phosphate—Urticaria—Methotrexate—breast cancer	2.76e-05	0.000141	CcSEcCtD
Histamine Phosphate—Abdominal pain—Methotrexate—breast cancer	2.75e-05	0.00014	CcSEcCtD
Histamine Phosphate—Body temperature increased—Methotrexate—breast cancer	2.75e-05	0.00014	CcSEcCtD
Histamine Phosphate—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.74e-05	0.00014	CcSEcCtD
Histamine Phosphate—Insomnia—Doxorubicin—breast cancer	2.72e-05	0.000139	CcSEcCtD
Histamine Phosphate—Paraesthesia—Doxorubicin—breast cancer	2.7e-05	0.000138	CcSEcCtD
Histamine Phosphate—Dyspnoea—Doxorubicin—breast cancer	2.68e-05	0.000137	CcSEcCtD
Histamine Phosphate—Feeling abnormal—Epirubicin—breast cancer	2.68e-05	0.000137	CcSEcCtD
Histamine Phosphate—Gastrointestinal pain—Epirubicin—breast cancer	2.66e-05	0.000135	CcSEcCtD
Histamine Phosphate—Dyspepsia—Doxorubicin—breast cancer	2.65e-05	0.000135	CcSEcCtD
Histamine Phosphate—Decreased appetite—Doxorubicin—breast cancer	2.61e-05	0.000133	CcSEcCtD
Histamine Phosphate—Gastrointestinal disorder—Doxorubicin—breast cancer	2.6e-05	0.000132	CcSEcCtD
Histamine Phosphate—Fatigue—Doxorubicin—breast cancer	2.59e-05	0.000132	CcSEcCtD
Histamine Phosphate—Urticaria—Epirubicin—breast cancer	2.58e-05	0.000132	CcSEcCtD
Histamine Phosphate—Pain—Doxorubicin—breast cancer	2.57e-05	0.000131	CcSEcCtD
Histamine Phosphate—Constipation—Doxorubicin—breast cancer	2.57e-05	0.000131	CcSEcCtD
Histamine Phosphate—Body temperature increased—Epirubicin—breast cancer	2.57e-05	0.000131	CcSEcCtD
Histamine Phosphate—Abdominal pain—Epirubicin—breast cancer	2.57e-05	0.000131	CcSEcCtD
Histamine Phosphate—Hypersensitivity—Methotrexate—breast cancer	2.56e-05	0.00013	CcSEcCtD
Histamine Phosphate—Asthenia—Methotrexate—breast cancer	2.49e-05	0.000127	CcSEcCtD
Histamine Phosphate—Feeling abnormal—Doxorubicin—breast cancer	2.48e-05	0.000126	CcSEcCtD
Histamine Phosphate—Gastrointestinal pain—Doxorubicin—breast cancer	2.46e-05	0.000125	CcSEcCtD
Histamine Phosphate—Pruritus—Methotrexate—breast cancer	2.46e-05	0.000125	CcSEcCtD
Histamine Phosphate—Hypersensitivity—Epirubicin—breast cancer	2.39e-05	0.000122	CcSEcCtD
Histamine Phosphate—Urticaria—Doxorubicin—breast cancer	2.39e-05	0.000122	CcSEcCtD
Histamine Phosphate—Abdominal pain—Doxorubicin—breast cancer	2.38e-05	0.000121	CcSEcCtD
Histamine Phosphate—Body temperature increased—Doxorubicin—breast cancer	2.38e-05	0.000121	CcSEcCtD
Histamine Phosphate—Diarrhoea—Methotrexate—breast cancer	2.38e-05	0.000121	CcSEcCtD
Histamine Phosphate—Asthenia—Epirubicin—breast cancer	2.33e-05	0.000119	CcSEcCtD
Histamine Phosphate—Pruritus—Epirubicin—breast cancer	2.3e-05	0.000117	CcSEcCtD
Histamine Phosphate—Dizziness—Methotrexate—breast cancer	2.3e-05	0.000117	CcSEcCtD
Histamine Phosphate—Diarrhoea—Epirubicin—breast cancer	2.22e-05	0.000113	CcSEcCtD
Histamine Phosphate—Hypersensitivity—Doxorubicin—breast cancer	2.22e-05	0.000113	CcSEcCtD
Histamine Phosphate—Vomiting—Methotrexate—breast cancer	2.21e-05	0.000113	CcSEcCtD
Histamine Phosphate—Rash—Methotrexate—breast cancer	2.19e-05	0.000112	CcSEcCtD
Histamine Phosphate—Dermatitis—Methotrexate—breast cancer	2.19e-05	0.000112	CcSEcCtD
Histamine Phosphate—Headache—Methotrexate—breast cancer	2.18e-05	0.000111	CcSEcCtD
Histamine Phosphate—Asthenia—Doxorubicin—breast cancer	2.16e-05	0.00011	CcSEcCtD
Histamine Phosphate—Dizziness—Epirubicin—breast cancer	2.15e-05	0.00011	CcSEcCtD
Histamine Phosphate—Pruritus—Doxorubicin—breast cancer	2.13e-05	0.000108	CcSEcCtD
Histamine Phosphate—Vomiting—Epirubicin—breast cancer	2.07e-05	0.000105	CcSEcCtD
Histamine Phosphate—Nausea—Methotrexate—breast cancer	2.06e-05	0.000105	CcSEcCtD
Histamine Phosphate—Diarrhoea—Doxorubicin—breast cancer	2.06e-05	0.000105	CcSEcCtD
Histamine Phosphate—Rash—Epirubicin—breast cancer	2.05e-05	0.000104	CcSEcCtD
Histamine Phosphate—Dermatitis—Epirubicin—breast cancer	2.05e-05	0.000104	CcSEcCtD
Histamine Phosphate—Headache—Epirubicin—breast cancer	2.04e-05	0.000104	CcSEcCtD
Histamine Phosphate—Dizziness—Doxorubicin—breast cancer	1.99e-05	0.000101	CcSEcCtD
Histamine Phosphate—Nausea—Epirubicin—breast cancer	1.93e-05	9.84e-05	CcSEcCtD
Histamine Phosphate—Vomiting—Doxorubicin—breast cancer	1.91e-05	9.75e-05	CcSEcCtD
Histamine Phosphate—Rash—Doxorubicin—breast cancer	1.9e-05	9.67e-05	CcSEcCtD
Histamine Phosphate—Dermatitis—Doxorubicin—breast cancer	1.89e-05	9.66e-05	CcSEcCtD
Histamine Phosphate—Headache—Doxorubicin—breast cancer	1.88e-05	9.6e-05	CcSEcCtD
Histamine Phosphate—Nausea—Doxorubicin—breast cancer	1.79e-05	9.11e-05	CcSEcCtD
Histamine Phosphate—HRH1—Signaling Pathways—HES1—breast cancer	3.87e-06	4.03e-05	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—PTEN—breast cancer	3.86e-06	4.02e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—NCOR1—breast cancer	3.84e-06	4e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—PLA2G4A—breast cancer	3.84e-06	4e-05	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—NCOA2—breast cancer	3.83e-06	3.99e-05	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—KRAS—breast cancer	3.82e-06	3.98e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—FGF1—breast cancer	3.8e-06	3.96e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—CSF2—breast cancer	3.8e-06	3.96e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling by GPCR—RAF1—breast cancer	3.79e-06	3.95e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—GSTA2—breast cancer	3.79e-06	3.95e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—GPX2—breast cancer	3.79e-06	3.95e-05	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—MAPK8—breast cancer	3.78e-06	3.93e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—NRG1—breast cancer	3.77e-06	3.93e-05	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling by GPCR—AKT1—breast cancer	3.77e-06	3.92e-05	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—FASN—breast cancer	3.75e-06	3.91e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—H2AFX—breast cancer	3.75e-06	3.9e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—GPCR downstream signaling—IL2—breast cancer	3.74e-06	3.9e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—SULT1A1—breast cancer	3.74e-06	3.9e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—GPX4—breast cancer	3.74e-06	3.9e-05	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—BCHE—breast cancer	3.74e-06	3.89e-05	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—HRAS—breast cancer	3.73e-06	3.89e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—E2F1—breast cancer	3.72e-06	3.87e-05	CbGpPWpGaD
Histamine Phosphate—CA4—Metabolism—AKT1—breast cancer	3.72e-06	3.87e-05	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—FASN—breast cancer	3.72e-06	3.87e-05	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—BCHE—breast cancer	3.7e-06	3.86e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling by GPCR—PIK3CB—breast cancer	3.7e-06	3.85e-05	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—SLC5A5—breast cancer	3.69e-06	3.84e-05	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Metabolism—PIK3CG—breast cancer	3.67e-06	3.82e-05	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—SLC5A5—breast cancer	3.66e-06	3.81e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—IDH1—breast cancer	3.66e-06	3.81e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—GSTA1—breast cancer	3.66e-06	3.81e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—NAT2—breast cancer	3.62e-06	3.76e-05	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—SRC—breast cancer	3.58e-06	3.73e-05	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—IL6—breast cancer	3.57e-06	3.72e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—SPP1—breast cancer	3.57e-06	3.72e-05	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—NQO1—breast cancer	3.56e-06	3.71e-05	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—SLC2A1—breast cancer	3.56e-06	3.71e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling by GPCR—CXCL8—breast cancer	3.56e-06	3.7e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—ERBB3—breast cancer	3.53e-06	3.68e-05	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—NQO1—breast cancer	3.53e-06	3.68e-05	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—SLC2A1—breast cancer	3.53e-06	3.68e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—FGFR2—breast cancer	3.53e-06	3.67e-05	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—PIK3CA—breast cancer	3.51e-06	3.66e-05	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—VEGFA—breast cancer	3.49e-06	3.63e-05	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—CYP3A4—breast cancer	3.48e-06	3.62e-05	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Metabolism—PIK3CD—breast cancer	3.46e-06	3.61e-05	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	3.46e-06	3.6e-05	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—STAT3—breast cancer	3.45e-06	3.6e-05	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—CYP3A4—breast cancer	3.45e-06	3.59e-05	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	3.43e-06	3.57e-05	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Metabolism—ALB—breast cancer	3.42e-06	3.56e-05	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—CYP1B1—breast cancer	3.42e-06	3.56e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling by GPCR—IL2—breast cancer	3.4e-06	3.54e-05	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—TP53—breast cancer	3.4e-06	3.54e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—TERT—breast cancer	3.39e-06	3.53e-05	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—CYP1B1—breast cancer	3.39e-06	3.53e-05	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—HSP90AA1—breast cancer	3.35e-06	3.49e-05	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—HSP90AA1—breast cancer	3.32e-06	3.46e-05	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—MAPK3—breast cancer	3.3e-06	3.44e-05	CbGpPWpGaD
Histamine Phosphate—HRH3—Signaling Pathways—AKT1—breast cancer	3.3e-06	3.43e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—FGFR1—breast cancer	3.29e-06	3.43e-05	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Metabolism—NOS3—breast cancer	3.27e-06	3.4e-05	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—NCOA1—breast cancer	3.26e-06	3.39e-05	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—HRAS—breast cancer	3.25e-06	3.38e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—HIF1A—breast cancer	3.24e-06	3.37e-05	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—NCOA1—breast cancer	3.23e-06	3.36e-05	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Metabolism—PIK3CD—breast cancer	3.23e-06	3.36e-05	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—STK11—breast cancer	3.21e-06	3.34e-05	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—CYP19A1—breast cancer	3.21e-06	3.34e-05	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—MYC—breast cancer	3.21e-06	3.34e-05	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—TGFB1—breast cancer	3.2e-06	3.33e-05	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Metabolism—ALB—breast cancer	3.19e-06	3.32e-05	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—STK11—breast cancer	3.18e-06	3.32e-05	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—CYP19A1—breast cancer	3.18e-06	3.32e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—MED12—breast cancer	3.17e-06	3.3e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—DPYD—breast cancer	3.17e-06	3.3e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—LEP—breast cancer	3.16e-06	3.29e-05	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—EGFR—breast cancer	3.14e-06	3.27e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—CAV1—breast cancer	3.13e-06	3.26e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—ALDOA—breast cancer	3.12e-06	3.25e-05	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—IL6—breast cancer	3.11e-06	3.24e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—KDR—breast cancer	3.1e-06	3.23e-05	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Metabolism—NOS3—breast cancer	3.05e-06	3.17e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—NCOA3—breast cancer	3.03e-06	3.15e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—ESR1—breast cancer	3.02e-06	3.14e-05	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Metabolism—PIK3CB—breast cancer	3.02e-06	3.14e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—SLC2A2—breast cancer	3.01e-06	3.13e-05	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Metabolism—PTGS2—breast cancer	2.99e-06	3.11e-05	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.99e-06	3.11e-05	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—COMT—breast cancer	2.99e-06	3.11e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—FN1—breast cancer	2.98e-06	3.11e-05	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—GSTP1—breast cancer	2.97e-06	3.09e-05	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—KRAS—breast cancer	2.97e-06	3.09e-05	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—COMT—breast cancer	2.96e-06	3.08e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—CPT1A—breast cancer	2.95e-06	3.07e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—ABCG2—breast cancer	2.95e-06	3.07e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—MTR—breast cancer	2.95e-06	3.07e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—NFKBIA—breast cancer	2.95e-06	3.07e-05	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—GSTP1—breast cancer	2.95e-06	3.07e-05	CbGpPWpGaD
Histamine Phosphate—SLC22A3—Metabolism—PIK3CA—breast cancer	2.93e-06	3.05e-05	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—HMOX1—breast cancer	2.93e-06	3.05e-05	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—ITPR1—breast cancer	2.92e-06	3.05e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—NOTCH1—breast cancer	2.92e-06	3.04e-05	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—HMOX1—breast cancer	2.91e-06	3.03e-05	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—ITPR1—breast cancer	2.9e-06	3.02e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—HPGDS—breast cancer	2.89e-06	3.01e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—HBA1—breast cancer	2.87e-06	2.99e-05	CbGpPWpGaD
Histamine Phosphate—HRH4—Signaling Pathways—AKT1—breast cancer	2.87e-06	2.99e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—PIK3CG—breast cancer	2.85e-06	2.97e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—APC—breast cancer	2.85e-06	2.97e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—KIT—breast cancer	2.85e-06	2.97e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—EGF—breast cancer	2.82e-06	2.94e-05	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Metabolism—PIK3CB—breast cancer	2.81e-06	2.93e-05	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—ABCB1—breast cancer	2.81e-06	2.93e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—ACHE—breast cancer	2.8e-06	2.92e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—GSTT1—breast cancer	2.8e-06	2.92e-05	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—ABCB1—breast cancer	2.79e-06	2.9e-05	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Metabolism—PTGS2—breast cancer	2.79e-06	2.9e-05	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—TYMS—breast cancer	2.76e-06	2.88e-05	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—TYMS—breast cancer	2.74e-06	2.85e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling by GPCR—MAPK3—breast cancer	2.73e-06	2.85e-05	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—PLA2G4A—breast cancer	2.73e-06	2.84e-05	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—GSTM1—breast cancer	2.73e-06	2.84e-05	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—NCOR1—breast cancer	2.73e-06	2.84e-05	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—PIK3CA—breast cancer	2.72e-06	2.84e-05	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—GSTM1—breast cancer	2.71e-06	2.82e-05	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—PLA2G4A—breast cancer	2.71e-06	2.82e-05	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—NCOR1—breast cancer	2.71e-06	2.82e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—BRAF—breast cancer	2.68e-06	2.79e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—CYP17A1—breast cancer	2.65e-06	2.76e-05	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—TP53—breast cancer	2.64e-06	2.74e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—ENO1—breast cancer	2.63e-06	2.74e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—PTGS1—breast cancer	2.63e-06	2.74e-05	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—GPX1—breast cancer	2.62e-06	2.72e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—IGF1—breast cancer	2.61e-06	2.72e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—AKT2—breast cancer	2.61e-06	2.72e-05	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Metabolism—PTEN—breast cancer	2.61e-06	2.72e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling by GPCR—EGFR—breast cancer	2.6e-06	2.71e-05	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—GPX1—breast cancer	2.59e-06	2.7e-05	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—CYP1A1—breast cancer	2.59e-06	2.7e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—CYP2D6—breast cancer	2.58e-06	2.68e-05	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—ERCC2—breast cancer	2.57e-06	2.67e-05	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—CYP1A1—breast cancer	2.57e-06	2.67e-05	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—ERCC2—breast cancer	2.55e-06	2.65e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—NCOA2—breast cancer	2.53e-06	2.63e-05	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—HRAS—breast cancer	2.52e-06	2.62e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—PIK3CD—breast cancer	2.51e-06	2.61e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—GPCR downstream signaling—PIK3CA—breast cancer	2.49e-06	2.59e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—SERPINE1—breast cancer	2.48e-06	2.58e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling by GPCR—KRAS—breast cancer	2.46e-06	2.56e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—FASN—breast cancer	2.45e-06	2.55e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—BCHE—breast cancer	2.44e-06	2.54e-05	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Metabolism—PTEN—breast cancer	2.43e-06	2.53e-05	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—MTHFR—breast cancer	2.41e-06	2.51e-05	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—IL6—breast cancer	2.41e-06	2.51e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—SLC5A5—breast cancer	2.41e-06	2.51e-05	CbGpPWpGaD
Histamine Phosphate—SLC22A3—Metabolism—AKT1—breast cancer	2.4e-06	2.5e-05	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—MTHFR—breast cancer	2.39e-06	2.49e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—NOS3—breast cancer	2.37e-06	2.47e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—NQO1—breast cancer	2.33e-06	2.43e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—SLC2A1—breast cancer	2.33e-06	2.43e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling by GPCR—PIK3CA—breast cancer	2.26e-06	2.35e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—MDM2—breast cancer	2.25e-06	2.34e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—RAF1—breast cancer	2.24e-06	2.33e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—CYP1B1—breast cancer	2.23e-06	2.33e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—RELA—breast cancer	2.23e-06	2.32e-05	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—CAV1—breast cancer	2.23e-06	2.32e-05	CbGpPWpGaD
Histamine Phosphate—HRH2—Signaling Pathways—AKT1—breast cancer	2.23e-06	2.32e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—ERBB2—breast cancer	2.22e-06	2.31e-05	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—CAV1—breast cancer	2.21e-06	2.3e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—HSP90AA1—breast cancer	2.19e-06	2.28e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—MTOR—breast cancer	2.19e-06	2.28e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—PIK3CB—breast cancer	2.19e-06	2.28e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—NCOA1—breast cancer	2.13e-06	2.22e-05	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.11e-06	2.2e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—CXCL8—breast cancer	2.1e-06	2.19e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—STK11—breast cancer	2.1e-06	2.19e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—CYP19A1—breast cancer	2.1e-06	2.19e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling by GPCR—HRAS—breast cancer	2.09e-06	2.17e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—CDKN1B—breast cancer	2.05e-06	2.14e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—GPCR downstream signaling—AKT1—breast cancer	2.03e-06	2.11e-05	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—PIK3CG—breast cancer	2.03e-06	2.11e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—CASP3—breast cancer	2.01e-06	2.09e-05	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—PIK3CG—breast cancer	2.01e-06	2.09e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—IL2—breast cancer	2.01e-06	2.09e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling by GPCR—IL6—breast cancer	2e-06	2.08e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—CCND1—breast cancer	1.96e-06	2.04e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—JUN—breast cancer	1.95e-06	2.03e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—COMT—breast cancer	1.95e-06	2.03e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—GSTP1—breast cancer	1.94e-06	2.02e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—CTNNB1—breast cancer	1.94e-06	2.02e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—HMOX1—breast cancer	1.92e-06	2e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—ITPR1—breast cancer	1.91e-06	1.99e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—MMP9—breast cancer	1.9e-06	1.98e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—CDKN1A—breast cancer	1.89e-06	1.97e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—PTEN—breast cancer	1.89e-06	1.97e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—MAPK8—breast cancer	1.85e-06	1.93e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling by GPCR—AKT1—breast cancer	1.84e-06	1.92e-05	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Metabolism—PIK3CA—breast cancer	1.84e-06	1.92e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—ABCB1—breast cancer	1.84e-06	1.92e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—TYMS—breast cancer	1.81e-06	1.88e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—GSTM1—breast cancer	1.79e-06	1.86e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.79e-06	1.86e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—NCOR1—breast cancer	1.79e-06	1.86e-05	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—PIK3CD—breast cancer	1.78e-06	1.86e-05	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—PIK3CD—breast cancer	1.77e-06	1.84e-05	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—ALB—breast cancer	1.76e-06	1.83e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—SRC—breast cancer	1.75e-06	1.82e-05	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—ALB—breast cancer	1.74e-06	1.82e-05	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Metabolism—PIK3CA—breast cancer	1.72e-06	1.79e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—GPX1—breast cancer	1.71e-06	1.78e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—VEGFA—breast cancer	1.71e-06	1.78e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—CYP1A1—breast cancer	1.69e-06	1.76e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—STAT3—breast cancer	1.69e-06	1.76e-05	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—NOS3—breast cancer	1.68e-06	1.75e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—ERCC2—breast cancer	1.68e-06	1.75e-05	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—NOS3—breast cancer	1.67e-06	1.74e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—MAPK3—breast cancer	1.61e-06	1.68e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—MTHFR—breast cancer	1.58e-06	1.64e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—MYC—breast cancer	1.57e-06	1.64e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—TGFB1—breast cancer	1.57e-06	1.63e-05	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—PIK3CB—breast cancer	1.55e-06	1.62e-05	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—PIK3CB—breast cancer	1.54e-06	1.6e-05	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—PTGS2—breast cancer	1.54e-06	1.6e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—EGFR—breast cancer	1.54e-06	1.6e-05	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—PTGS2—breast cancer	1.53e-06	1.59e-05	CbGpPWpGaD
Histamine Phosphate—SLC22A2—Metabolism—AKT1—breast cancer	1.5e-06	1.57e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—CAV1—breast cancer	1.46e-06	1.52e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—KRAS—breast cancer	1.45e-06	1.51e-05	CbGpPWpGaD
Histamine Phosphate—SLC22A1—Metabolism—AKT1—breast cancer	1.4e-06	1.46e-05	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—PTEN—breast cancer	1.34e-06	1.4e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—PIK3CA—breast cancer	1.33e-06	1.39e-05	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—PTEN—breast cancer	1.33e-06	1.39e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—PIK3CG—breast cancer	1.33e-06	1.38e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—TP53—breast cancer	1.29e-06	1.34e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—HRAS—breast cancer	1.23e-06	1.28e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—IL6—breast cancer	1.18e-06	1.23e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—PIK3CD—breast cancer	1.17e-06	1.21e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—ALB—breast cancer	1.15e-06	1.2e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—NOS3—breast cancer	1.1e-06	1.15e-05	CbGpPWpGaD
Histamine Phosphate—HRH1—Signaling Pathways—AKT1—breast cancer	1.09e-06	1.13e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—PIK3CB—breast cancer	1.02e-06	1.06e-05	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—PTGS2—breast cancer	1.01e-06	1.05e-05	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—PIK3CA—breast cancer	9.47e-07	9.86e-06	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—PIK3CA—breast cancer	9.39e-07	9.78e-06	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—PTEN—breast cancer	8.78e-07	9.14e-06	CbGpPWpGaD
Histamine Phosphate—CYP2D6—Metabolism—AKT1—breast cancer	7.74e-07	8.06e-06	CbGpPWpGaD
Histamine Phosphate—CYP2C9—Metabolism—AKT1—breast cancer	7.67e-07	7.99e-06	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—PIK3CA—breast cancer	6.19e-07	6.45e-06	CbGpPWpGaD
Histamine Phosphate—CYP3A4—Metabolism—AKT1—breast cancer	5.06e-07	5.27e-06	CbGpPWpGaD
